Rhodium (II) butyrate: a potential anticancer drug with cell cycle phase-specific effects in HeLa cells.
D000970:Antineoplastic Agents; D002087:Butyrates / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects*; D002869:Chromosome Aberrations; D002875:Chromosomes / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006367:HeLa Cells; D006801:Humans; D012238:Rhodium / Q000494:pharmacology*; D012854:Sister Chromatid Exchange / Q000187:drug effects
D000970:Antineoplastic Agents; D002087:Butyrates; D012238:Rhodium